Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Artificial Organs|December 21, 2000
The use of electrolyzed solutions for the cleaning and disinfecting of dialyzersN Tanaka, N Tanaka, T Fujisawa, et al.
Scanning Microscopy|March 1, 1991
Microprobe analyses of the potassium-calcium distribution relationship in predentineH J Höhling, H Mishima, Y Kozawa, et al.
Insect Molecular Biology|June 16, 2010
Transgenic analysis of the BmBLOS2 gene that governs the translucency of the larval integument of the silkworm, Bombyx moriT Fujii, T Daimon, K Uchino, et al.
British Journal of Cancer|February 20, 2008
Intra-arterial chemoradiotherapy for locally advanced oral cavity cancer: analysis of therapeutic results in 134 casesN Fuwa, T Kodaira, K Furutani, et al.
The British Journal of Radiology|July 17, 2008
Identifying patients with peripheral-type early non-small cell lung cancer (T1N0M0) for whom irradiation of the primary focus alone could lead to successful treatmentN Fuwa, T Daimon, T Mitsudomi, et al.
The British Journal of Radiology|August 31, 2006
Relationship between the growth pattern of nasopharyngeal cancer and the cervical lymph nodes based on MRI findings: can the cervical radiation field be reduced in patients with nasopharyngeal cancer?N Fuwa, Y Ariji, T Daimon, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 24, 2013
Particle therapy for mucosal melanoma of the head and neck. A single-institution retrospective comparison of proton and carbon ion therapyY Demizu, O Fujii, K Terashima, et al.
The British Journal of Radiology|April 1, 2009
Reproducibility of temporal volume change in CT of lung cancer: comparison of computer software and manual assessmentO Honda, M Kawai, T Gyobu, et al.
The British Journal of Radiology|November 30, 2013
Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordomaM Mima, Y Demizu, D Jin, et al.
The Pharmacogenomics Journal|June 1, 2016
Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics studyD Tsuji, M Yokoi, K Suzuki, et al.
Pageof 6